Does BUPROPION Cause Neoplasm malignant? 18 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neoplasm malignant have been filed in association with BUPROPION (Bupropion Hydrochloride (XL)). This represents 0.1% of all adverse event reports for BUPROPION.
18
Reports of Neoplasm malignant with BUPROPION
0.1%
of all BUPROPION reports
2
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm malignant From BUPROPION?
Of the 18 reports, 2 (11.1%) resulted in death, 6 (33.3%) required hospitalization, and 5 (27.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUPROPION. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does BUPROPION Cause?
Completed suicide (5,095)
Drug ineffective (3,991)
Toxicity to various agents (3,837)
Depression (2,486)
Overdose (2,357)
Headache (2,323)
Anxiety (2,145)
Intentional overdose (2,103)
Drug hypersensitivity (1,967)
Seizure (1,894)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which BUPROPION Alternatives Have Lower Neoplasm malignant Risk?
BUPROPION vs BUPROPION HYDROBROMIDE
BUPROPION vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE
BUPROPION vs BUPROPION\NALTREXONE
BUPROPION vs BUROSUMAB
BUPROPION vs BUROSUMAB-TWZA